Stenting of the iliac arteries with the palmaz stent: Experience from a multicenter trial

Julio C. Palmaz; Jean C. Laborde; Frank J. Rivera; Carlos E. Encarnacion; James D. Lutz; Jonathan G. Moss

doi:10.1007/BF02733953

Stenting of the iliac arteries with the palmaz stent: Experience from a multicenter trial

Julio C. Palmaz, Jean C. Laborde, Frank J. Rivera, Carlos E. Encarnacion, James D. Lutz, Jonathan G. Moss

Department of Radiology

Research output: Contribution to journal › Article › peer-review

295 Scopus citations

Abstract

Balloon-expandable, intraluminal stenting of the iliac arteries with the Palmaz stent was the subject of a multicenter study for 4 years. A total of 486 patients underwent 587 procedures. Four hundred and five patients had unilateral and 81 had bilateral iliac stent placements. Follow-up ranged from 1 to 48 months (mean 13.3±11 months). Sustained clinical benefit of the treated patients was obtained in 90.9% at 1 year, 84.1% at 2 years, and 68.6% at 43 months. Angiographic patency rate was 92%. Diabetes mellitus and poor runoff had significant negative influence on the clinical outcome. The 10% incidence of procedural complications was not altered by operator experience.

Original language	English (US)
Pages (from-to)	291-297
Number of pages	7
Journal	Cardiovascular and Interventional Radiology
Volume	15
Issue number	5
DOIs	https://doi.org/10.1007/BF02733953
State	Published - Sep 1992

Keywords

Atherosclerosis
Iliac arteries
Intravascular stents
Percutaneous balloon angioplasty

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Radiology Nuclear Medicine and imaging

Access to Document

10.1007/BF02733953

Cite this

@article{904aaa1773274ca3bd3e9c5148898c9b,

title = "Stenting of the iliac arteries with the palmaz stent: Experience from a multicenter trial",

abstract = "Balloon-expandable, intraluminal stenting of the iliac arteries with the Palmaz stent was the subject of a multicenter study for 4 years. A total of 486 patients underwent 587 procedures. Four hundred and five patients had unilateral and 81 had bilateral iliac stent placements. Follow-up ranged from 1 to 48 months (mean 13.3±11 months). Sustained clinical benefit of the treated patients was obtained in 90.9% at 1 year, 84.1% at 2 years, and 68.6% at 43 months. Angiographic patency rate was 92%. Diabetes mellitus and poor runoff had significant negative influence on the clinical outcome. The 10% incidence of procedural complications was not altered by operator experience.",

keywords = "Atherosclerosis, Iliac arteries, Intravascular stents, Percutaneous balloon angioplasty",

author = "Palmaz, {Julio C.} and Laborde, {Jean C.} and Rivera, {Frank J.} and Encarnacion, {Carlos E.} and Lutz, {James D.} and Moss, {Jonathan G.}",

year = "1992",

month = sep,

doi = "10.1007/BF02733953",

language = "English (US)",

volume = "15",

pages = "291--297",

journal = "Cardiovascular and Interventional Radiology",

issn = "0174-1551",

publisher = "Springer",

number = "5",

}

TY - JOUR

T1 - Stenting of the iliac arteries with the palmaz stent

T2 - Experience from a multicenter trial

AU - Palmaz, Julio C.

AU - Laborde, Jean C.

AU - Rivera, Frank J.

AU - Encarnacion, Carlos E.

AU - Lutz, James D.

AU - Moss, Jonathan G.

PY - 1992/9

Y1 - 1992/9

N2 - Balloon-expandable, intraluminal stenting of the iliac arteries with the Palmaz stent was the subject of a multicenter study for 4 years. A total of 486 patients underwent 587 procedures. Four hundred and five patients had unilateral and 81 had bilateral iliac stent placements. Follow-up ranged from 1 to 48 months (mean 13.3±11 months). Sustained clinical benefit of the treated patients was obtained in 90.9% at 1 year, 84.1% at 2 years, and 68.6% at 43 months. Angiographic patency rate was 92%. Diabetes mellitus and poor runoff had significant negative influence on the clinical outcome. The 10% incidence of procedural complications was not altered by operator experience.

AB - Balloon-expandable, intraluminal stenting of the iliac arteries with the Palmaz stent was the subject of a multicenter study for 4 years. A total of 486 patients underwent 587 procedures. Four hundred and five patients had unilateral and 81 had bilateral iliac stent placements. Follow-up ranged from 1 to 48 months (mean 13.3±11 months). Sustained clinical benefit of the treated patients was obtained in 90.9% at 1 year, 84.1% at 2 years, and 68.6% at 43 months. Angiographic patency rate was 92%. Diabetes mellitus and poor runoff had significant negative influence on the clinical outcome. The 10% incidence of procedural complications was not altered by operator experience.

KW - Atherosclerosis

KW - Iliac arteries

KW - Intravascular stents

KW - Percutaneous balloon angioplasty

UR - http://www.scopus.com/inward/record.url?scp=0026479109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026479109&partnerID=8YFLogxK

U2 - 10.1007/BF02733953

DO - 10.1007/BF02733953

M3 - Article

C2 - 1423389

AN - SCOPUS:0026479109

SN - 0174-1551

VL - 15

SP - 291

EP - 297

JO - Cardiovascular and Interventional Radiology

JF - Cardiovascular and Interventional Radiology

IS - 5

ER -

Stenting of the iliac arteries with the palmaz stent: Experience from a multicenter trial

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this